Efficacy and Safety of Varenicline for Smoking Cessation

Mortality in relation to smoking: 40 years' observations on male British doctors

1994 • 5,782 citations

Actual Causes of Death in the United States

1993 • 5,506 citations

Actual Causes of Death in the United States, 2000

2004 • 5,189 citations

Mortality in relation to smoking: 50 years' observations on male British doctors

2004 • 2,718 citations

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,630 citations

Cigarette Smoking Among Adults--United States, 2003

2005 • 1,531 citations

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,343 citations

[Actual causes of death].

1951 • 1,029 citations

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

2005 • 922 citations

Nicotinic Receptors at the Amino Acid Level

2000 • 795 citations

Mortality from smoking in developed countries 1950-2000

1996 • 758 citations

Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

2004 • 685 citations

Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 664 citations

Neural Mechanisms of Drug Reinforcementa

1992 • 610 citations

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

2005 • 544 citations

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

2006 • 534 citations

Tobacco control country profiles

2003 • 517 citations

Pharmacology and behavioral pharmacology of the mesocortical dopamine system

2001 • 478 citations

Relapse prevention interventions for smoking cessation

2013 • 444 citations

Mortality from smoking in developed countries, 1950-2000: indirect estimates from national vital statistics

1995 • 443 citations

Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist

2006 • 392 citations

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

2006 • 380 citations

Neurobiology of Nicotine Addiction: Implications for Smoking Cessation Treatment

2008 • 361 citations

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation

2001 • 343 citations

Nicotine: from molecular mechanisms to behaviour

2004 • 260 citations

Neuronal Systems Underlying Behaviors Related to Nicotine Addiction: Neural Circuits and Molecular Genetics

2002 • 259 citations

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

1994 • 255 citations

Cytisine for Smoking Cessation

2006 • 182 citations

Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes

2003 • 89 citations

Extended treatment with bupropion SR for cigarette smoking cessation.

2006 • 82 citations

Relapse prevention interventions for smoking cessation

2005 • 65 citations

The Role of beta2-Subunit-Containing Nicotinic Acetylcholine Receptors in the Brain Explored with a Mutant Mouse

1999 • 28 citations